Integer Holdings [ITGR] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Integer Holdings Corporation

NYSE
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Integer Holdings Corporation wins in 8 metrics, Abbott Laboratories wins in 11 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Integer Holdings Corporation Abbott Laboratories Better
P/E Ratio (TTM) 29.47 25.97 Abbott Laboratories
Price-to-Book Ratio 1.67 3.09 Integer Holdings Corporation
Debt-to-Equity Ratio 75.45 26.79 Abbott Laboratories
PEG Ratio 11.79 -1.41 Integer Holdings Corporation
EV/EBITDA 11.22 13.74 Integer Holdings Corporation
Profit Margin (TTM) 5.55% 13.90% Abbott Laboratories
Operating Margin (TTM) 12.79% 16.50% Abbott Laboratories
EBITDA Margin (TTM) 12.79% 16.50% Abbott Laboratories
Return on Equity 6.11% 12.36% Abbott Laboratories
Return on Assets (TTM) 4.75% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $105.12M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return -24.74% -35.92% Integer Holdings Corporation
Price-to-Sales Ratio (TTM) 1.58 3.57 Integer Holdings Corporation
Enterprise Value $4.23B $166.96B Abbott Laboratories
EV/Revenue Ratio 2.28 3.70 Integer Holdings Corporation
Gross Profit Margin (TTM) 26.43% N/A N/A
Revenue per Share (TTM) $53 $26 Integer Holdings Corporation
Earnings per Share (Diluted) $2.89 $3.57 Abbott Laboratories
Beta (Stock Volatility) 0.71 0.78 Integer Holdings Corporation
Short % of Float 12.99% 1.53% Abbott Laboratories

Integer Holdings Corporation vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

ITGR
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Integer Holdings Corporation0.64%2.16%8.27%4.77%30.07%18.38%
Abbott Laboratories0.02%1.53%-0.63%-23.43%-30.57%-29.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Integer Holdings Corporation-24.74%6.01%4.12%171.75%223.72%283.11%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: Integer Holdings Corporation vs Abbott Laboratories

MetricITGRABT
Market Information
Market Cap i$2.92B$160.70B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i318,21413,495,583
90 Day Avg. Volume i614,83112,934,461
Last Close$90.89$86.99
52 Week Range$62.00 - $123.78$81.97 - $139.06
% from 52W High-26.57%-37.44%
All-Time High$146.36 (Jan 27, 2025)$142.60 (Dec 27, 2021)
% from All-Time High-37.90%-39.00%
Growth Metrics
Quarterly Revenue Growth0.05%0.08%
Quarterly Earnings Growth0.49%-0.19%
Financial Health
Profit Margin (TTM) i0.06%0.14%
Operating Margin (TTM) i0.13%0.17%
Return on Equity (TTM) i0.06%0.12%
Debt to Equity (MRQ) i75.4526.79
Cash & Liquidity
Book Value per Share (MRQ)$50.85$30.02
Cash per Share (MRQ)$0.50$5.14
Operating Cash Flow (TTM) i$196.15M$10.80B
Levered Free Cash Flow (TTM) i$76.88M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Integer Holdings Corporation vs Abbott Laboratories

MetricITGR (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i29.4725.97
Forward P/E i11.7915.29
PEG Ratio i11.79-1.41
Price to Sales (TTM) i1.583.57
Price to Book (MRQ) i1.673.09
Market Capitalization
Market Capitalization i$2.92B$160.70B
Enterprise Value i$4.23B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i2.283.70
Enterprise to EBITDA i11.2213.74
Risk & Other Metrics
Beta i0.710.78
Book Value per Share (MRQ) i$50.85$30.02

Financial Statements Comparison: Integer Holdings Corporation vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricITGR (2025)ABT (2025)
Revenue/Sales i1.85B44.33B
Cost of Goods Sold i1.35B19.32B
COGS % of Revenue i73.0%43.6%
Gross Profit i500.39M25.01B
Gross Margin i27.0%56.4%
Research & Development i49.50M2.94B
Operating Income (EBIT) i239.14M8.05B
Operating Margin i12.9%18.2%
EBITDA i311.16M12.03B
EBITDA Margin i16.8%27.1%
Pre-Tax Income i125.40M8.47B
Pre-Tax Income % of Revenue i6.8%19.1%
Income Tax i22.57M1.94B
Income Tax % of Revenue i1.2%4.4%
Net Income (Profit) i102.81M6.52B
Profit Margin i5.5%14.7%

Balance Sheet & Liquidity Metrics

MetricITGR (2025)ABT (2025)
Cash & Equivalents i17.16M8.52B
Total Current Assets i770.10M26.00B
Total Current Assets % of Revenue i41.5%58.6%
Total Current Liabilities i232.04M16.50B
Total Current Liabilities % of Revenue i12.5%37.2%
Long-Term Debt i1.30B10.83B
Long-Term Debt % of Revenue i69.9%24.4%
Total Shareholders Equity i1.75B52.77B
Retained Earnings i994.06M49.78B
Retained Earnings % of Revenue i53.6%112.3%
Property, Plant & Equipment i137.17M17.57B

Cash Flow Statement Comparison

MetricITGR (2025)ABT (2025)
Operating Cash Flow i224.32M10.80B
Operating Cash Flow % of Revenue i12.1%24.4%
Capital Expenditures i-91.03M-2.17B
Free Cash Flow i105.12M7.40B
FCF Margin i5.7%16.7%
Debt Repayment i-1.11B-1.50B
Common Stock Repurchase i-50.01M-893.00M

Short Interest & Institutional Ownership Analysis

MetricITGRABT
Shares Short i3.72M23.83M
Short Ratio i4.641.93
Short % of Float i12.99%1.53%
Shares Outstanding i34.35M1.74B
Float Shares i33.99M1.73B
% Held by Insiders i1.47%0.54%
% Held by Institutions i112.63%82.23%
% Held by Public i-14.10%17.23%

Dividend Analysis & Yield Comparison: Integer Holdings Corporation vs Abbott Laboratories

MetricITGRABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026